Efficacy and safety of nitazoxanide plus atazanavir/ritonavir for the treatment of moderate to severe COVID-19 (NACOVID): A structured summary of a study protocol for a randomised controlled trial

Citation:
Olagunju, A, Adeola F, Olagunoye A, Ojo T, Adefuye B, Fagbamigbe A, Adebiyi A, Olagunju O, Ladipo O, Akinloye A, Adeagbo B, Onayade A, Bolaji O, Happi C, Rannard S, Owen A.  2021.  Efficacy and safety of nitazoxanide plus atazanavir/ritonavir for the treatment of moderate to severe COVID-19 (NACOVID): A structured summary of a study protocol for a randomised controlled trial, 12. Trials. 22

Abstract:

n/a

Notes:

n/a